Focusing on osteoarthritis treatment, β-hydroxybutyrate has been demonstrated to ameliorate osteoarthritis through the activation of the ERBB3 signaling pathway in mice (Cai et al., 2024). The gene discussed is ERBB3; the disease is osteoarthritis.